Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy - Wikidata - wikimedia - TriplyDB

Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy

Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy

http://www.wikidata.org/entity/Q33607465

about

Preeclampsia: long-term consequences for vascular health Cytokines as key players in the pathophysiology of preeclampsia Elucidating immune mechanisms causing hypertension during pregnancy Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia The role of inflammation in the pathology of preeclampsia 17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy.Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α.The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia.Identifying immune mechanisms mediating the hypertension during preeclampsia Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.Animal models of pre-eclampsia.Mechanism of the protective effects of the combined treatment with rhynchophylla total alkaloids and sinapine thiocyanate against a prothrombotic state caused by vascular endothelial cell inflammatory damage Effect of 17-alpha hydroxyprogesterone caproate on the production of tumor necrosis factor-alpha and the expression of cyclooxygenase-2 in lipopolysaccharide-treated gravid human myometrial explants.Continued Investigation Into 17-OHPC: Results From the Preclinical RUPP Rat Model of Preeclampsia.Assessment of ADMA, estradiol, and progesterone in severe preeclampsia.Interleukin-6 contributes to myocardial damage in pregnant rats with reduced uterine perfusion pressure.

P2860

Q26800272-39111493-BE46-40F6-A736-FBAA569DEC01 Q26830707-401C49B5-456E-46C2-B933-C579010DF7B8 Q26852668-CCACECBB-E70C-4C82-8931-156F4CECDF9A Q33736407-18ABC51E-74A8-479D-AF00-54F93633ED4F Q33834419-4A2E0A31-06DA-4870-AF14-09BD9DE877FC Q35151065-DFE1A4D3-A001-43A0-A0F6-FD3F9D3EF6EC Q36407259-2B333741-5FC1-40DA-9B5F-8FF1CC4CD722 Q36528002-A5708FB8-52EA-4AA5-B8CD-E0F855C0BE30 Q37088970-BF757A68-80A2-4339-81CF-7EFA0D55A39A Q37139722-4ED1BCA8-238D-49D4-A0F9-88D95289DF18 Q37229246-2F97FF2C-7E16-4F75-B0EC-EBEBF61A8414 Q37816496-8A9B8CA8-4FAB-4E33-8A7E-03C3718DE4C8 Q42235431-85C067D3-1DA3-408E-ADD4-865D3761737A Q43134456-B8D13EDC-50C7-4F6D-A604-E1FCC237BFFD Q47688833-343C69DA-94E1-4E34-8AF0-C8789D7AABEB Q50651982-884F2CA5-C8C4-4C43-A799-EFA9184C382C Q55470760-0F9E2455-15B4-4C29-84D2-72A0A14D136E

P2860

Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy

http://www.wikidata.org/entity/Q33607465

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Effects of 17-hydroxyprogester ...... hypertension during pregnancy

@ast

Effects of 17-hydroxyprogester ...... hypertension during pregnancy

@en

type

label

Effects of 17-hydroxyprogester ...... hypertension during pregnancy

@ast

Effects of 17-hydroxyprogester ...... hypertension during pregnancy

@en

prefLabel

Effects of 17-hydroxyprogester ...... hypertension during pregnancy

@ast

Effects of 17-hydroxyprogester ...... hypertension during pregnancy

@en

P1433

Q33607465-096DF85D-42D5-438C-81F1-8C6A387A316C

P1476

Q33607465-E3D63186-16D7-4219-8A87-9BABE86BCD22

P2093

Q33607465-08D66ECF-85AE-4268-BD82-E4D75C954341

Q33607465-28C7FB8D-3BA3-46A8-AD09-A55BB7E45BC5

Q33607465-48DD4052-14EC-445E-A370-FF804F0C8CC5

Q33607465-4AED5487-C400-4F5B-8832-28994BDA98BA

Q33607465-52CF0DA5-D98F-458F-8D33-BA69B8688B31

Q33607465-87150F90-183C-4EC8-B472-AD1B7873E378

Q33607465-A4BFFADF-EECF-435D-93EE-6A1B8AA6EF60

Q33607465-B8C2BD8D-65FB-4AC1-A9EA-D668B4426B5F

Q33607465-E5F10288-0AC4-4D83-8329-7A29F19D2321

P2860

Q33607465-036A1496-46CE-4524-91C0-B7A33A243BDC

Q33607465-1E728D4D-5EC8-4B47-B651-47F6CDBAF8BC

Q33607465-3375C970-71EB-4802-B3A3-35D5EEAC73A3

Q33607465-3CA62D6C-18AF-44D3-9512-277A3A1C77A3

Q33607465-41CAB70F-39E0-4DF7-881D-E715C83F0290

Q33607465-6E94B4FC-E48B-4F93-9B06-60DE442F18E2

Q33607465-739EBECC-21E7-46F2-BBA0-272A7D77C84B

Q33607465-87F4AA5D-4E9B-440E-98CB-6D6E1E8BA32D

Q33607465-8FF61782-6F6C-4474-BFDD-96A7AB3C831D

Q33607465-9511F0FA-097E-4296-AE6B-0DC5492A8083

P304

Q33607465-46D0AA0E-3FCD-4F8B-875F-30C011C0A65F

P31

Q33607465-38A9D28C-24F1-42BC-9BAE-D43A887144DD

P356

Q33607465-816B7CF0-BEE2-4194-9ACD-6C9322E920D8

P433

Q33607465-7B76E053-13BE-4EED-9DEC-F4C2C262C408

P478

Q33607465-3A186DC3-C3F4-40AC-BC41-7A53686093BF

P577

Q33607465-674981D7-F13D-42FB-A0FA-B104FF0EE32A

P5875

Q33607465-706F0553-23E0-47E3-87FB-C4605A8ECFC7

P698

Q33607465-785931C9-7C89-4095-80DC-8B3FF9015B56

P932

Q33607465-28E10814-513C-4E84-86AE-042581454195

P356

P1433

American Journal of Hypertension

P1476

Effects of 17-hydroxyprogester ...... hypertension during pregnancy

@en

P2093

Babbette Lamarca

http://www.w3.org/2001/XMLSchema#string

Edward W Veillon

http://www.w3.org/2001/XMLSchema#string

James N Martin

http://www.w3.org/2001/XMLSchema#string

Joey P Granger

http://www.w3.org/2001/XMLSchema#string

Kathy Cockrell

http://www.w3.org/2001/XMLSchema#string

Lillian Fournier

http://www.w3.org/2001/XMLSchema#string

Marc R Parrish

http://www.w3.org/2001/XMLSchema#string

Sharon D Keiser

http://www.w3.org/2001/XMLSchema#string

William Bennett

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate

Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1

Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy.

Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.

Preeclampsia: recent insights.

Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens.

Mechanisms of progesterone action in inhibiting prematurity.

Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia.

Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats.

P304

1120-1125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJH.2009.149

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26804077

http://www.w3.org/2001/XMLSchema#string

P698

19745821

http://www.w3.org/2001/XMLSchema#string

P932

2810643

http://www.w3.org/2001/XMLSchema#string